ZA851642B - A pharmaceutical formulation containing azapropazone - Google Patents

A pharmaceutical formulation containing azapropazone

Info

Publication number
ZA851642B
ZA851642B ZA851642A ZA851642A ZA851642B ZA 851642 B ZA851642 B ZA 851642B ZA 851642 A ZA851642 A ZA 851642A ZA 851642 A ZA851642 A ZA 851642A ZA 851642 B ZA851642 B ZA 851642B
Authority
ZA
South Africa
Prior art keywords
azapropazone
pharmaceutical formulation
formulation containing
carboxylate
molar ratio
Prior art date
Application number
ZA851642A
Other languages
English (en)
Inventor
Kim Drummond Rainsford
Michael Wellesley Whitehouse
Original Assignee
Kim Drummond Rainsford
Whitehouse Michael W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Drummond Rainsford, Whitehouse Michael W filed Critical Kim Drummond Rainsford
Publication of ZA851642B publication Critical patent/ZA851642B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA851642A 1984-03-08 1985-03-05 A pharmaceutical formulation containing azapropazone ZA851642B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08406055A GB2155329A (en) 1984-03-08 1984-03-08 A pharmaceutical formulation containing azapropazone

Publications (1)

Publication Number Publication Date
ZA851642B true ZA851642B (en) 1985-10-30

Family

ID=10557766

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851642A ZA851642B (en) 1984-03-08 1985-03-05 A pharmaceutical formulation containing azapropazone

Country Status (15)

Country Link
US (1) US5034379A (fr)
EP (1) EP0154523B1 (fr)
JP (1) JPS60215635A (fr)
AT (1) ATE41603T1 (fr)
AU (1) AU572968B2 (fr)
CA (1) CA1256803A (fr)
DE (1) DE3568943D1 (fr)
DK (1) DK106485A (fr)
ES (1) ES8800598A1 (fr)
GB (1) GB2155329A (fr)
NO (1) NO850913L (fr)
NZ (1) NZ211294A (fr)
PH (1) PH21053A (fr)
PT (1) PT80078B (fr)
ZA (1) ZA851642B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668676A (en) * 1985-12-06 1987-05-26 E.I. Du Pont De Nemours And Company Azapropazone prevention of post-ischemic tissue damage
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
EP0278997A1 (fr) * 1987-02-17 1988-08-24 Siegfried Aktiengesellschaft Capsules rectales d'azapropazone
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
WO1993018775A1 (fr) * 1992-03-19 1993-09-30 The University Of British Columbia Procede et composition permettant de supprimer les effets secondaires de medicaments anti-inflammatoires
WO1993023055A1 (fr) * 1992-05-15 1993-11-25 The University Of British Columbia Glucosamine d'acetyle-n en tant qu'agent gastroprotecteur
GB9321655D0 (en) * 1993-10-20 1993-12-08 Glyzinc Pharma Ltd Pharmaceutical formulation of aspirin and salicylates
FR2836656B1 (fr) * 2002-03-01 2004-05-28 Michelin Soc Tech Dispositif et procede de traitement des phenomenes de perte de pression et de roulage a plat des pneumatiques d'un vehicule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU511852B2 (en) * 1977-11-09 1980-09-11 Australian National University, The Formulating aspirin andthe like
DE2966867D1 (en) * 1979-01-12 1984-05-10 Univ Australian Protection of the gastric mucosal lining from damage by aspirin and related drugs
EP0028660B1 (fr) * 1979-11-10 1985-10-23 Siegfried Aktiengesellschaft Inhibiteurs de la xanthine oxydase et application des dérivés de la benzotriazine

Also Published As

Publication number Publication date
PH21053A (en) 1987-07-03
US5034379A (en) 1991-07-23
EP0154523B1 (fr) 1989-03-22
PT80078B (en) 1987-02-23
ES541054A0 (es) 1987-11-16
DK106485A (da) 1985-09-09
PT80078A (en) 1985-04-01
ATE41603T1 (de) 1989-04-15
AU572968B2 (en) 1988-05-19
CA1256803A (fr) 1989-07-04
GB8406055D0 (en) 1984-04-11
NZ211294A (en) 1987-09-30
JPS60215635A (ja) 1985-10-29
DK106485D0 (da) 1985-03-08
EP0154523A3 (en) 1986-06-04
AU3950685A (en) 1985-09-12
DE3568943D1 (en) 1989-04-27
GB2155329A (en) 1985-09-25
EP0154523A2 (fr) 1985-09-11
NO850913L (no) 1985-09-09
ES8800598A1 (es) 1987-11-16

Similar Documents

Publication Publication Date Title
EP0276501A3 (en) Thickening compositions and thickened aqueous acid solutions
AU5226796A (en) Water insoluble derivatives of polyanionic polysaccharides
EP0259939A3 (en) Aqueous polysaccharide compositions
GB1463966A (en) Depilatory formulation
PL340580A1 (en) Dibenzylidene sorbitol containing antiperspirant
ES2062161T3 (es) Forma liquida estable de acido 5-aminosalicilico.
IL75598A0 (en) Stabilized aqueous solutions of 5-chloro-3-isothiazolones,their preparation and their use
EP0080293A3 (en) Fluoride containing dentifrice
DE3568943D1 (en) A pharmaceutical formulation containing azapropazone
EP0941999A3 (fr) Préparation de dihydrate d'azithromycine
IE780076L (en) Antimicrobial compositions
GB9019875D0 (en) Pharmaceutical compositions
ES2014764A6 (es) Un metodo para preparar una composicion de superoxido-dismutasa.
ES2061829T3 (es) Solucion acuosa, estable frente al almacenamiento, de alquiltrialcoxisilanos.
YU26790A (en) Pentamidine solutions
AU610592B2 (en) Aqueous alkali metal halogenite compositions
GB1394764A (en) 2,5-hexanedione
GB8514315D0 (en) Preparation of aqueous solution
GB1532550A (en) Agent for preventing cold turbidity in beer
CA2026575A1 (fr) Solutions stables de tetraphenylborate de sodium
DE3777881D1 (de) Entchlorung waesseriger alkalimetallchloridloesungen.
EP0437621A4 (en) Aqueous solution of motilin
MY100362A (en) Astringent dentifrice
SE7613849L (sv) For injicering ferdigstellda losningar
GB1216131A (en) Stable, aqueous nystatin preparations